Clin2
NCT07796204Possibly a fitNot yet recruiting

Almonds to improve nutrition during weight-loss medication

ObesityType 2 Diabetes

Part of Hormones & metabolism clinical trials.

This study tests whether eating almonds can help people on weight-loss medications like semaglutide or tirzepatide get better nutrition. It may help you maintain muscle and get important vitamins while losing weight.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
76 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have type 2 diabetes and a BMI of 27 or higher, or you have obesity (BMI 30 or higher).
  • You are already prescribed a branded injectable weight-loss medication (semaglutide or tirzepatide) and have at least a two-month supply.
  • You have not used a GLP-1 medication in the last 3 months.
  • You are not allergic to almonds.
  • You have not had bariatric surgery.
  • You are not pregnant or breastfeeding.
  • You are willing to start the study before you begin your medication (if you haven't started yet).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06885736Recruiting
Preserving muscle with exercise and protein on weight loss drugs

This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.

Kuwait City
NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama
NCT05071898Recruiting· Phase 1
Studying how genetics affect response to GLP-1 weight-loss drugs

This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.

Lancaster, Pennsylvania
NCT07654374Recruiting· Phase 3
Study of a new pill for weight loss and diabetes

This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.

Birmingham, Alabama
NCT06411210Recruiting· Phase 2
Weight loss medication for young adults with type 1 diabetes

This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.

New Haven, Connecticut
NCT07411378Not yet recruiting· Phase 2
Study of a plant extract with semaglutide for weight loss

This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.